Compare 8x8 Inc (EGHT) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
8x8 Inc vs Novartis AG — how do they compare? 8x8 Inc trades at $2.13 (market cap $309.09M), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 955.6× 8x8 Inc's market cap, and Novartis AG pays a 3.07% dividend while 8x8 Inc pays none. Which is the better fit depends on your goals.
| EGHT | NVS | |
|---|---|---|
Market Cap | $309.09M | $295.37B |
Sector | Technology | Health |
52-Week High | $2.76 | $168.62 |
52-Week Low | $1.59 | $119.31 |
Enterprise Value | $576.02M | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 8x8 Inc
8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.
Read more on EGHT →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
